IDEAYA Biosciences, Inc. - Common Stock (IDYA)
CUSIP: 45166A102
Q2 2022 13F Holders as of 30 Jun 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 87,836,000
- Total 13F shares
- 35,430,856
- Share change
- +466,205
- Total reported value
- $488,943,386
- Price per share
- $13.80
- Number of holders
- 95
- Value change
- +$8,388,194
- Number of buys
- 37
- Number of sells
- 51
Quarterly Holders Quick Answers
What is CUSIP 45166A102?
CUSIP 45166A102 identifies IDYA - IDEAYA Biosciences, Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 45166A102:
Top shareholders of IDYA - IDEAYA Biosciences, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Logos Global Management LP |
13F
|
Company |
3.2%
|
2,850,000
|
$31,892,000 | — | 31 Mar 2022 | |
| Avidity Partners Management LP |
13F
|
Company |
3.1%
|
2,690,000
|
$30,101,000 | — | 31 Mar 2022 | |
| Canaan Partners X LLC |
13F
|
Company |
3%
|
2,660,713
|
$29,774,000 | — | 31 Mar 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2.8%
|
2,490,277
|
$27,866,000 | — | 31 Mar 2022 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
2.6%
|
2,249,180
|
$25,169,000 | — | 31 Mar 2022 | |
| Boxer Capital, LLC |
13F
|
Company |
2.5%
|
2,202,812
|
$24,649,000 | — | 31 Mar 2022 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
2.4%
|
2,114,993
|
$23,667,000 | — | 31 Mar 2022 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,870,370
|
$20,929,000 | — | 31 Mar 2022 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
2.1%
|
1,847,017
|
$20,668,000 | — | 31 Mar 2022 | |
| BVF INC/IL |
13F
|
Company |
1.8%
|
1,600,559
|
$17,910,000 | — | 31 Mar 2022 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.8%
|
1,576,257
|
$17,638,000 | — | 31 Mar 2022 | |
| 5AM Venture Management, LLC |
13F
|
Company |
1.6%
|
1,398,066
|
$15,644,000 | — | 31 Mar 2022 | |
| FMR LLC |
13F
|
Company |
1.1%
|
992,474
|
$11,106,000 | — | 31 Mar 2022 | |
| PLATINUM INVESTMENT MANAGEMENT LTD |
13F
|
Company |
1.1%
|
952,561
|
$10,659,000 | — | 31 Mar 2022 | |
| Alphabet Inc. |
13F
|
Company |
0.86%
|
753,187
|
$8,428,000 | — | 31 Mar 2022 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.7%
|
614,610
|
$6,877,000 | — | 31 Mar 2022 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.56%
|
490,061
|
$5,484,000 | — | 31 Mar 2022 | |
| JANUS HENDERSON GROUP PLC |
13F
|
Company |
0.51%
|
446,627
|
$5,001,000 | — | 31 Mar 2022 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.48%
|
425,183
|
$4,758,000 | — | 31 Mar 2022 | |
| CITADEL ADVISORS LLC |
13F
|
Company |
0.41%
|
360,592
|
$4,035,000 | — | 31 Mar 2022 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.34%
|
302,569
|
$3,386,000 | — | 31 Mar 2022 | |
| Michael P. Dillon |
3/4/5
|
SVP, Chief Scientific Officer |
—
mixed-class rows
|
102,226
mixed-class rows
|
$3,311,116 | — | 04 Oct 2021 | |
| AXA S.A. |
13F
|
Company |
0.32%
|
282,104
|
$3,156,744 | — | 31 Mar 2022 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.29%
|
258,329
|
$2,891,000 | — | 31 Mar 2022 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.22%
|
196,537
|
$2,199,000 | — | 31 Mar 2022 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
0.22%
|
193,301
|
$2,163,000 | — | 31 Mar 2022 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.22%
|
191,987
|
$2,149,000 | — | 31 Mar 2022 | |
| ACT CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.2%
|
173,500
|
$1,941,000 | — | 31 Mar 2022 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.19%
|
166,805
|
$1,867,000 | — | 31 Mar 2022 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.19%
|
165,586
|
$1,853,000 | — | 31 Mar 2022 | |
| Nuveen Asset Management, LLC |
13F
|
Company |
0.17%
|
149,607
|
$1,743,000 | — | 31 Mar 2022 | |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC |
13F
|
Company |
0.12%
|
109,000
|
$1,623,000 | — | 31 Mar 2022 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.14%
|
125,972
|
$1,410,000 | — | 31 Mar 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0.14%
|
120,830
|
$1,352,000 | — | 31 Mar 2022 | |
| Bank of New York Mellon Corp |
13F
|
Company |
0.13%
|
112,906
|
$1,263,000 | — | 31 Mar 2022 | |
| Rafferty Asset Management, LLC |
13F
|
Company |
0.12%
|
108,939
|
$1,219,000 | — | 31 Mar 2022 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.11%
|
94,781
|
$1,061,000 | — | 31 Mar 2022 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.1%
|
85,572
|
$958,000 | — | 31 Mar 2022 | |
| TWO SIGMA ADVISERS, LP |
13F
|
Company |
0.09%
|
79,200
|
$886,000 | — | 31 Mar 2022 | |
| UBS Group AG |
13F
|
Company |
0.09%
|
76,371
|
$854,000 | — | 31 Mar 2022 | |
| Cubist Systematic Strategies, LLC |
13F
|
Company |
0.09%
|
75,704
|
$847,000 | — | 31 Mar 2022 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.08%
|
66,295
|
$742,000 | — | 31 Mar 2022 | |
| HRT FINANCIAL LP |
13F
|
Company |
0.07%
|
65,226
|
$729,000 | — | 31 Mar 2022 | |
| Swiss National Bank |
13F
|
Company |
0.07%
|
63,800
|
$714,000 | — | 31 Mar 2022 | |
| JACOB ASSET MANAGEMENT OF NEW YORK LLC |
13F
|
Company |
0.07%
|
62,929
|
$704,000 | — | 31 Mar 2022 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
0.07%
|
61,541
|
$688,000 | — | 31 Mar 2022 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.07%
|
59,970
|
$670,605 | — | 31 Mar 2022 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.06%
|
54,778
|
$613,000 | — | 31 Mar 2022 | |
| GSA CAPITAL PARTNERS LLP |
13F
|
Company |
0.06%
|
54,215
|
$607,000 | — | 31 Mar 2022 | |
| HighVista Strategies LLC |
13F
|
Company |
0.06%
|
49,527
|
$554,000 | — | 31 Mar 2022 |
Institutional Holders of IDEAYA Biosciences, Inc. - Common Stock (IDYA) as of Q2 2022
As of 30 Jun 2022,
IDEAYA Biosciences, Inc. - Common Stock (IDYA) was held by
95 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
35,430,856 shares.
The largest 10 holders included
Logos Global Management LP, Avidity Partners Management LP, BVF INC/IL, Canaan Partners X LLC, BlackRock Inc., BOXER CAPITAL, LLC, FEDERATED HERMES, INC., PRICE T ROWE ASSOCIATES INC /MD/, VANGUARD GROUP INC, and Point72 Asset Management, L.P..
This page lists
95
institutional shareholders reporting positions in this security
for the Q2 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2022 vs Q1 2022 Across Filers
Q1 2022 holders
100
Q2 2022 holders
95
Holder diff
-5
| Investor | Q1 2022 Shares | Q2 2022 Shares | Share Diff | Share Chg % | Q1 2022 Value $ | Q2 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.